Abstract
Climatic droplet keratopathy (CDK) is an acquired degenerative disease predominantly affecting males over 40 years old. It results in progressive corneal opacities usually affecting both eyes. CDK is multifactorial and its etiology remains unknown. Our recent findings are consistent with CDK pathology being driven by environmental factors with oxidative stress playing an important role (for example, contributing to lipid peroxidation) rather than climate factors. The changes in corneal lipid composition affected by environmental factors remain understudied. The purpose of this study was to systematically investigate phospholipids profile [phosphatidylcholine (PC) and phosphatidylserine (PS)] in corneas from CDK patients using tandem mass spectrometry. Samples from CDK areas and from non-affected areas were obtained from patients diagnosed with CDK who underwent cataract surgery, were subjected to lipid extraction using a modified Bligh and Dyer method; protein concentrations were determined using the Bradford’s method. Lipids were identified and subjected to ratiometric quantification using TSQ Quantum Access Max triple quadrupole mass spectrometer, using appropriate class specific lipid standards. All phospholipid classes showed lower total amounts in affected areas compared to control areas from CDK’s corneas. Comparative profiles of two phospholipid classes (PC, PS) between CDK areas and control areas showed several common species between them. We also found a few unique lipids that were absent in CDK areas compared to controls and vice versa. Lower amount of phospholipids in CDK areas compared to control areas could be attributed to the lipid peroxidation in the affected corneal regions as a consequence of increased oxidative stress.
Keywords: CDK, Phospholipids, Phosphatidylcholine, Phosphatidylserine, Cornea, Tandem mass spectrometry
Climatic droplet keratopathy (CDK) is a bilateral degenerative corneal disease related to advanced age, lifestyle, and multiple environmental factors such as corneal micro traumas, low humidity and lack of adequate protection for exposure to ultraviolet radiation (UVR) (Suarez et al., 2015). CDK most commonly affects males over 40 years old, in the form of progressive opacities of the anterior layers of the cornea. This disease is rare in temperate latitudes, and it is commonly linked to overexposure to UVR, being endemic in certain rural communities around the world. Since the first description of the disease in 1898 (Baquis), CDK has been reported in different parts of the world following different criterions (presumed aetiology, geographic area, by eponym, clinical presentation, nature of corneal deposits and patient’s activities) and more recently in the Patagonia region of Argentina, as has been reviewed by Serra et al. (2015).
CDK slowly progresses to corneal opacity, through three grades of increasing severity. In the initial stages (grade 1), multiple tiny and tightly confluent translucent extracellular sub epithelial deposits, located in the Bowman layer close to the temporal and/or nasal limbus, giving the affected cornea a tarnished, hazy aspect. In grade 2, haziness spreads over the inferior 2/3rds of the cornea, affecting the central cornea. At this stage, visual acuity may be moderate to severely affected due to the visual axis involvement. Grade 3 is characterized by the presence of large golden sub-epithelial droplets of different sizes (some of them are 1 mm in diameter) grouped in clusters that grow and cover the cornea as the disease progresses. In advanced cases, areas of vascularized anterior stromal opacification or fibrosis may be observed. In general, corneal sensitivity and visual acuity are severely affected at this stage (Freedman, 1965; Urrets-Zavalia et al., 2007).
Another clinical finding observed in some of our patients in the Argentinian Patagonia is a mild to severe atrophy of the 1/2 inferior iris stroma, more frequently observed in grades 2 and 3 (Urrets-Zavalía et al., 2007). Despite the harsh environmental conditions in which individuals from this region live, dry eye was not common among CDK patients, or controls (Urrets-Zavalía et al., 2007).
We have investigated the biological features of matrix metalloproteinases (MMPs) and their inhibitors TIMPs in patients with CDK, as these molecules control the degradation of the corneal epithelium and stroma. Our studies showed enhanced MMP-2 and MMP-9 levels and a decreased expression of TIMP-1 in CDK patients’ tears (Holopainen et al., 2011). Immunohistochemistry showed that MMP-2 was expressed at the basement membrane zone in both control and affected corneas, but also marked the edges of the granular CDK deposits; MMP-9 expression was restrained to basal layers of the epithelium and was markedly induced in CDK corneas (Holopainen et al., 2012). We also investigated the effect of UVR in the production of MMPs and cytokines using an in vitro cellular model of immortalized human corneal epithelial cells (HCE). Exposure of HCE cells to UVR significantly increased MMP and pro-inflammatory cytokine secretion, suggesting an active participation of the corneal epithelium on CDK’s pathogenesis (Holopainen et al., 2012).
Many advances that could help to understand ethiopathogenic mechanisms involved in CDK have been made in the last years, recently reviewed by Serra et al (2015).
Lipids constitute a unique group of biomolecules that mediate a large number of functional and structural activities in the cell, tending to maintain homeostasis (Checa et al., 2015), and constitute about 5% of the weight of mammalian cells (Fahy et al., 2009). Cellular lipids are highly complex and dynamic (Yang and Han, 2016). There is evidence that phospholipids may play an important role in the regulation of several ocular homeostatic mechanisms due to their presence in aqueous humor and subsequent changes under injury conditions (Liliom et al., 1998). Lipids are also important components of the tear film. The lipid layer is highly organized, consisting of a monolayer of phospholipids at the water-air interface, which provides a hydrophobic interface on which non-polar lipids expand (Rantamäki et al., 2011). Defects in the lipid layer of the tear film results in increased evaporation, which perpetuates ocular surface inflammation and damage. Also, lipids have been involved in ocular surface pathologies such as dry eye, allergic keratoconjunctivitis, infections and glaucoma (Ham et al., 2004; Robciuc et al., 2014; Fujishima et al., 2013; Aribindi et al., 2013a; Edwards et al., 2014).
There are no previous reports on identification or determination of superficial corneal lipid composition of patients with CDK. Lipid peroxidation may occur at the epithelium of the cornea exposed to prolonged exposure to UVR without adequate protection, in certain individuals under certain circumstances, which could result in an oxidative stress. Our aim was to systematically study lipids in corneal epithelial cells from CDK corneas using tandem mass spectrometry, and identify a differential composition, if any, between healthy corneal epithelial areas and CDK affected areas.
MATHERIAL AND METHODS
Tissue samples procurement
The samples were procured according to the protocol approved by institutional review process and the tenets of the Declaration of Helsinki. Corneal epithelial cell specimens from the eyes of two CDK patients (a 62-year old and 63-year old males) (Figure 1) at the moment of a planned cataract surgery were obtained and kept at −70° C until they were further processed. One CDK affected area, and one control non-affected area, were collected by scraping these regions of the cornea using a crescent knife. No abnormalities of the iris were observed biomicroscopically, and the ocular tensions, as well as the ocular fundus were normal in both eyes patients.
Figure 1.

Slit-lamp images of corneas in two CDK patients (A and C), and in vivo confocal microscopy (B and D). Grade 1 disease with peripheral nasal haziness (A) and grade 2 with diffuse haziness affecting also the central cornea (C), caused by tiny droplets of different sizes visualized with magnification and back-scattered slit-illumination. CDK grade 1 presents dot-like deposits at the level of Bowman’s layer and (B), and CDK grade 2 shows an increase in the density of the hyperreflective dot-like deposits in Bowman’s layer and superficial stroma (D).
Lipid extraction
Corneal tissue was subjected to lipid extraction using a modified Bligh and Dyer method (Iverson et al., 2001). The organic phase with extracted lipids was dried in a Speed-Vac (Model 7810014, Labconco, Kansas City, MO, USA). Samples were flushed with argon gas to prevent oxidation. All extractions and subsequent handling were made using glass vials; polyvinyl plastic was avoided completely to prevent contaminating impurities. Corresponding aqueous phase extracted proteins were subjected to determination of concentration using Bradford’s method (Bradford, 1976), and these concentrations were used to normalize lipids per amount of proteins.
Mass spectrometry
Dried lipid samples were re-suspended in LC-MS grade Acetonitrile: Isopropanol (1:1). Samples were infused with a flow rate of 5μl/min, using Tri Versa Nanomate (Advion Inc., Ithaca, NY, USA), a chip-based electrospray ionization machine controlled with Chipsoft8.3.3 version software.
A triple quadrupole electrospray mass spectrometer (TSQ Quantum Access Max; Thermo Fisher Scientific, Pittsburgh, PA, USA) was used for analysis of lipids in infusion mode using TSQ Tune software that is part of the Xcaliber 2.3 software package. Samples were analyzed for 2.00 minutes with a 0.500-second scan. Scans typically ranged from 200 to 1000 m/z. A peak width was set at 0.7 and collision gas pressure was set at 1 mTorr. Sheath gas (nitrogen) was set to 20 arbitrary units. Auxiliary gas (Argon) was set to 5 arbitrary units. Settings for analyses of different phospholipid classes were established based on previous studies (Enriquez-Algeciras and Bhattacharya, 2013). The 0.1% formic acid (FA) was used as an additive method for analyses of lipids in the positive ion mode only (that is, for analyses of PC but not for PS). Control and CDK corneal epithelial cells were utilized for each of the two different class of phospholipid analyzed. Class specific lipids were quantified using class specific quantitative lipid standards:1,2-ditridecanoyl-sn-glycero-3-phosphocholine and 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) (Avanti Polar Lipids, Inc; Alabaster, AL, USA). Approximately 5 scans each with and without internal standard (usually in the range of 0.1–10pmol) were performed for each sample. Ratiometric quantification was achieved using the MZmine 2.9 program. Lipid concentration was normalized to protein amount determined from the corresponding aqueous phase as described above.
Representative spectra for each sample were carefully and manually inspected by two independent observers from 5 spectra collected for each sample with and without the internal standard (total 10 spectra) and then used for further analyses. Spectra were converted to netCDF files from Thermo RAW files using the Xcalibur 2.3 software suite, subsequently imported into MZmine 2.9 (Edwards et al., 2014). Identification was carried out against a custom database created from the Lipid Maps Database (LMDB).
Identified lipids were subjected to analysis for determination of common and unique species using an Excel macro (Aribindi et al., 2013b). We defined unique when a given lipid species was found in only one group (control areas or CDK affected areas). Common species are those that have been found in samples from both control and CDK affected areas of both patients. All unique lipid experimental readings (the amount of lipid species pM/μg protein) were found to be significantly different from 0.0 by one sample t-test (p≤0.05).
Statistical analysis
Student’s t-test was used for comparison between lipid concentrations in control areas vs CDK affected areas. A p-value ≤0.05 was considered significant.
RESULTS
We obtained lipid profiles for two classes of phospholipids: phosphatidylcholine (PC) and phosphatidylserine (PS), using established parameters (Enriquez-Algeciras and Bhattacharya, 2013). A representative PC and PS spectrum for control corneal samples without and with ratiometric standards (Fig. 2 A, 3A and Fig. 2 B, 3B, respectively) are shown. Using Excel Macros all data from two phospholipids were analyzed to determine the presence of common and unique lipid species in control areas and CDK affected areas.
Figure 2.

Representative electro spray ionization tandem mass spectrometric analysis of PC lipid class extracted from CDK human corneal epithelium control area, in positive ion mode. (A) A parent ion scan (PIS) scanning of m/z =184.0 for PC class. (B) Representative PIS as presented above with internal standard addition (arrow; m/z= 650.3, 10pmol) to perform ratiometric quantification of all identified lipids in PC class.
Figure 3.

Representative electro spray ionization tandem mass spectrometric analysis of PS lipid class extracted from CDK human corneal epithelium control area, in neutral loss scan (NLS). (A) NLS scanning of m/z =87.1 for PS class. (B) Representative NLS as presented above with internal standard addition (arrow; m/z= 810.63, 10pmol) to perform ratiometric quantification of all identified lipids in PS class.
All phospholipids classes showed higher total amounts in control areas compared to CDK affected areas. In grade 1, total phospholipids amount was 7.6 times higher in control than in CDK areas. In grade 2, phospholipids concentration was 35 times higher in control areas than in CDK affected areas. PC and PS concentrations were higher in the control than in CDK area in grade 1 (4.7 times and 10 times, respectively) as well as in grade 2 (5.7 times and 36 times, respectively). The total amount of all two classes of phospholipids normalized to total amount of proteins in the corresponding aqueous phase extractions are presented in table 1.
Table 1.
Total average protein normalized phosphatidylcholine and phosphatidylserine in the CDK corneal specimens.
| Patient / CDK grade | Phosphatidylcholines (pmol/μg protein) | Phosphatidylserines (pmol/μg protein) | Total phospholipids amount (pmol/μg protein) | |||
|---|---|---|---|---|---|---|
| Control | CDK | Control | CDK | Control | CDK | |
| Grade 1 | 11792.35 | 2510.78 | 29936.93 | 2981.93 | 41729.28 | 5492.71 |
| Grade 2 | 2583.76 | 450.44 | 489172.16 | 13572.31 | 491755.92 | 14022.75 |
We found 35 unique PC species in the control areas and 38 species in CDK affected areas from grade 1 patient’s sample. No unique PC species were found in samples from grade 2 (table 2, figure 4). For common lipids, we found 47 common PC species in control and CDK affected areas in grade 1 and 85 common PC species for grade 2 (table 3, figure 4).
Table 2.
Unique phospholipid species identified in control and CDK affected areas.
| m/z* | Amount, pmol per Species/μg protein | LIPIDMAPS ID | |
|---|---|---|---|
| Phosphatydilcholines | |||
| Grade 1 | |||
| Control | |||
| PC(6:2(2E,4E)/6:2(2E,4E)) | 449.5343475 | 35.10504116 | LMGP01011235 |
| PC(6:0/6:0) | 461.611969 | 60.97552036 | LMGP01011229 |
| PC(8:2(2E,4E)/8:2(2E,4E)) | 508.7760621 | 336.7085264 | LMGP01011254 |
| PC(O-16:0/2:0) | 532.708313 | 30.49454999 | LMGP01020046 |
| PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) | 576.223999 | 27.63661101 | LMGP01050056 |
| PC(12:0/14:1(9Z)) | 653.0681152 | 188.8764232 | LMGP01011316 |
| PC(18:0/11:1(10E)) | 697.8502197 | 123.003872 | LMGP01010735 |
| PC(12:0/18:4(6Z,9Z,12Z,15Z)) | 705.4578247 | 16.83355497 | LMGP01011326 |
| PC(13:0/18:4(6Z,9Z,12Z,15Z)) | 719.3928223 | 261.6877919 | LMGP01011351 |
| PC(14:0/18:4(6Z,9Z,12Z,15Z)) | 734.7036133 | 33.99468733 | LMGP01010499 |
| PC(14:0/18:3(9Z,12Z,15Z)) | 736.7713623 | 139.3388865 | LMGP01010497 |
| PC(O-16:0/17:2(9Z,12Z)) | 739.5371704 | 10.7416212 | LMGP01020184 |
| PC(10:0/22:0) | 743.0431061 | 95.55680672 | LMGP01010397 |
| PC(14:0/20:5(5Z,8Z,11Z,14Z,17Z)) | 760.842041 | 14.79965082 | LMGP01010508 |
| PC(14:0/20:4(5Z,8Z,11Z,14Z)) | 761.8012695 | 11.29438532 | LMGP01010506 |
| PC(16:0/18:3(6Z,9Z,12Z)) | 764.8153687 | 16.84177156 | LMGP01010598 |
| PC(13:0/22:2(13Z,16Z)) | 780.9053548 | 141.4017152 | LMGP01011360 |
| PC(18:0/18:2(10Z,12Z)) | 793.9078979 | 4.870731935 | LMGP01010764 |
| PC(15:1(9Z)/22:4(7Z,10Z,13Z,16Z)) | 802.3403931 | 0.292454956 | LMGP01011460 |
| PC(16:0/22:6(4E,7E,10E,13E,16E,19E)) | 814.689621 | 35.41917971 | LMGP01010650 |
| PC(16:0/22:4(7Z,10Z,13Z,16Z)) | 818.5667572 | 35.02464907 | LMGP01010642 |
| PC(18:0/20:2(11Z,14Z)) | 822.8417358 | 3.113532506 | LMGP01010788 |
| PC(17:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 829.2927246 | 19.62032538 | LMGP01010720 |
| PC(18:0/22:3(10Z,13Z,16Z)) | 848.0913086 | 10.55761574 | LMGP01010812 |
| PC(20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z)) | 861.9257813 | 12.02594653 | LMGP01011058 |
| PC(20:3(8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 864.4815369 | 96.29052353 | LMGP01011896 |
| PC(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 869.3223114 | 4.978646959 | LMGP01011834 |
| PC(23:0/18:0) | 869.6445313 | 9.01741973 | LMGP01011130 |
| PC(20:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 870.8692932 | 18.18734822 | LMGP01011028 |
| PC(20:0/22:5(7Z,10Z,13Z,16Z,19Z)) | 871.7922363 | 63.0557569 | LMGP01011027 |
| PC(20:1(11Z)/22:2(13Z,16Z)) | 877.6144409 | 0.34022481 | LMGP01011832 |
| PC(22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 890.7302246 | 10.41447043 | LMGP01012096 |
| PC(22:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 897.191803 | 58.34030765 | LMGP01012034 |
| PC(22:1(11Z)/22:2(13Z,16Z)) | 905.4731445 | 11.1785486 | LMGP01012032 |
| PC(20:0/24:1(15Z)) | 908.4393921 | 55.37025535 | LMGP01011032 |
| CDK | |||
| PC(P-15:0/0:0) | 475.3136597 | 2.258060045 | LMGP01070003 |
| PC(0:0/14:0) | 475.7080078 | 8.760073598 | LMGP01050073 |
| PC(17:2(9Z,12Z)/0:0) | 512.0413666 | 139.3999566 | LMGP01050127 |
| PC(20:3(8Z,11Z,14Z)/0:0) | 555.0397949 | 9.151008296 | LMGP01050133 |
| PC(10:0/10:0) | 574.9521484 | 58.01008602 | LMGP01010380 |
| PC(16:0/9:0(COOH)) | 674.8492432 | 43.25367692 | LMGP20010007 |
| PC(12:0/17:2(9Z,12Z)) | 695.5105082 | 59.84938759 | LMGP01011322 |
| PC(12:0/18:3(6Z,9Z,12Z)) | 709.3492432 | 29.40629858 | LMGP01011324 |
| PC(13:0/18:3(6Z,9Z,12Z)) | 722.7244721 | 23.22549354 | LMGP01011349 |
| PC(14:0/18:2(11Z,14Z)) | 738.9689941 | 9.61773106 | LMGP01010494 |
| PC(14:0/18:1(11Z)) | 740.4227498 | 10.14359376 | LMGP01010490 |
| PC(13:0/20:3(8Z,11Z,14Z)) | 751.0203247 | 6.071596573 | LMGP01011355 |
| PC(15:0/18:1(11Z)) | 754.4980469 | 16.34204123 | LMGP01010541 |
| PC(10:0/23:0) | 757.4887085 | 7.0248453 | LMGP01010399 |
| PC(16:0/18:2(10E,12Z)) | 765.9030151 | 19.37539039 | LMGP01010585 |
| PC(16:0/18:1(9Z)) | 767.6375427 | 5.401143878 | LMGP01010005 |
| PC(18:2(9Z,12E)/17:2(9Z,11E)) | 777.0445557 | 8.175188459 | LMGP01010931 |
| PC(14:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 787.3533936 | 8.379876858 | LMGP01010512 |
| PC(16:0/20:5(5Z,8Z,11Z,14Z,17Z)) | 789.5361938 | 5.682940604 | LMGP01010633 |
| PC(18:0/18:1(11Z)) | 797.3813477 | 1.802717735 | LMGP01010750 |
| PC(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 812.9232788 | 5.572865494 | LMGP01010696 |
| PC(17:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 823.7950745 | 5.964470179 | LMGP01011580 |
| PC(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 836.2522125 | 8.435849515 | LMGP01011670 |
| PC(18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 838.1468811 | 2.276002421 | LMGP01010947 |
| PC(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 842.451416 | 5.65016685 | LMGP01010821 |
| PC(18:0/22:5(4Z,7Z,10Z,13Z,16Z)) | 844.7405396 | 0.22199696 | LMGP01010816 |
| PC(16:0/24:1(15Z)) | 852.4516602 | 0.506300409 | LMGP01010659 |
| PC(19:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 854.8773652 | 7.943575465 | LMGP01011786 |
| PC(19:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 857.3092651 | 0.602203978 | LMGP01011755 |
| PC(19:1(9Z)/22:4(7Z,10Z,13Z,16Z)) | 858.6088867 | 0.439391289 | LMGP01011785 |
| PC(16:0/26:2(5Z,9Z)) | 878.7354736 | 7.857161887 | LMGP01010665 |
| PC(16:0/26:0) | 882.1089478 | 3.17402956 | LMGP01010663 |
| PC(22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 899.3740845 | 6.28295672 | LMGP01012003 |
| PC(22:1(11Z)/22:4(7Z,10Z,13Z,16Z)) | 900.31604 | 4.064865082 | LMGP01012033 |
| PC(22:0/22:4(7Z,10Z,13Z,16Z)) | 902.128006 | 12.31269729 | LMGP01012002 |
| PC(22:1(13E)/22:1(13E)) | 906.6358643 | 8.243314415 | LMGP01011108 |
| PC(18:0/26:0) | 910.7911377 | 23.81364481 | LMGP01010828 |
| PC(20:0/26:0) | 938.448761 | 5.159413759 | LMGP01011034 |
| Phosphatydilserines | |||
| Grade 1 | |||
| Control | |||
| PS(15:0/0:0) | 486.2679443 | 349.4908061 | LMGP03050031 |
| PS(16:1(9Z)/0:0) | 490.930191 | 1351.894279 | LMGP03050010 |
| PS(18:0/0:0) | 530.1671143 | 456.3458717 | LMGP03050006 |
| PS(20:0/0:0) | 554.648584 | 684.5651013 | LMGP03050012 |
| PS(22:0/0:0) | 585.0875854 | 179.8953782 | LMGP03050025 |
| PS(14:1(9Z)/14:1(9Z)) | 670.7094727 | 32.97216305 | LMGP03010919 |
| PS(12:0/22:2(13Z,16Z)) | 756.0275879 | 97.04654863 | LMGP03010066 |
| PS(13:0/22:2(13Z,16Z)) | 769.5744629 | 191.1471607 | LMGP03010090 |
| PS(18:0/18:1(9Z)) | 792.4706421 | 41.71102472 | LMGP03010025 |
| PS(17:0/22:2(13Z,16Z)) | 826.5164795 | 394.1171434 | LMGP03010246 |
| PS(17:0/22:1(11Z)) | 826.6235962 | 173.221204 | LMGP03010245 |
| PS(19:0/22:2(13Z,16Z)) | 853.6619873 | 434.259899 | LMGP03010477 |
| PS(22:0/22:2(13Z,16Z)) | 894.7367554 | 5.440477649 | LMGP03010723 |
| CDK | |||
| PS(22:1(11Z)/0:0) | 580.0860748 | 33.72772797 | LMGP03050023 |
| PS(12:0/16:1(9Z)) | 673.6097412 | 6.176727075 | LMGP03010049 |
| PS(12:0/20:2(11Z,14Z)) | 728.3601685 | 57.60975185 | LMGP03010060 |
| PS(13:0/22:4(7Z,10Z,13Z,16Z)) | 766.5620728 | 2.502793177 | LMGP03010091 |
| PS(18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 829.5198975 | 4.677840797 | LMGP03010045 |
| PS(19:0/21:0) | 852.2431335 | 50.02072802 | LMGP03010474 |
| PS(20:0/22:2(13Z,16Z)) | 868.54953 | 7.575445338 | LMGP03010526 |
| PS(21:0/22:0) | 890.7318624 | 57.13378798 | LMGP03010698 |
| Grade 2 | |||
| Control | |||
| PS(12:0/0:0) | 439.9199524 | 20160.19245 | LMGP03050008 |
| PS(16:1(9Z)/0:0) | 492.0351257 | 16760.19337 | LMGP03050010 |
| PS(19:1(9Z)/0:0) | 535.6446533 | 38229.62984 | LMGP03050019 |
| PS(22:4(7Z,10Z,13Z,16Z)/0:0) | 575.9509277 | 5370.664303 | LMGP03050014 |
| PS(22:0/0:0) | 584.8668213 | 399.0301165 | LMGP03050025 |
| PS(12:0/13:0) | 639.6738281 | 1485.057448 | LMGP03010001 |
| PS(14:0/12:0) | 655.169632 | 2134.979121 | LMGP03010931 |
| PS(12:0/15:1(9Z)) | 658.8825073 | 1073.721191 | LMGP03010048 |
| PS(14:1(9Z)/14:1(9Z)) | 672.0128784 | 5326.561203 | LMGP03010919 |
| PS(14:0/14:0) | 681.993866 | 1454.833471 | LMGP03010028 |
| PS(13:0/18:2(9Z,12Z)) | 713.6038208 | 1105.076469 | LMGP03010078 |
| PS(12:0/20:2(11Z,14Z)) | 727.508667 | 1256.958181 | LMGP03010060 |
| PS(12:0/22:2(13Z,16Z)) | 754.8304749 | 664.3245694 | LMGP03010066 |
| PS(13:0/22:4(7Z,10Z,13Z,16Z)) | 767.3230438 | 4198.550223 | LMGP03010091 |
| PS(17:0/21:0) | 824.0448914 | 1161.380728 | LMGP03010243 |
| PS(17:0/22:1(11Z)) | 827.3017273 | 109.6109416 | LMGP03010245 |
| PS(19:0/22:2(13Z,16Z)) | 853.5385742 | 42064.46901 | LMGP03010477 |
| PS(20:0/22:2(13Z,16Z)) | 867.8551636 | 711.0927161 | LMGP03010526 |
| PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 877.0893402 | 1496.288525 | LMGP01030017 |
| CDK | |||
| PS(18:2(9Z,12Z)/0:0) | 517.1746216 | 44.51834435 | LMGP03050011 |
| PS(18:0/0:0) | 529.024292 | 152.087076 | LMGP03050006 |
| PS(12:0/16:1(9Z)) | 674.1259766 | 2.737743873 | LMGP03010049 |
| PS(13:0/18:3(6Z,9Z,12Z)) | 711.3513184 | 24.13983471 | LMGP03010079 |
| PS(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 805.9547729 | 13.41827269 | LMGP03010043 |
| PS(18:0/20:4(5Z,8Z,11Z,14Z)) | 815.3720093 | 125.3012959 | LMGP03010039 |
| PS(17:0/22:2(13Z,16Z)) | 826.2357788 | 277.8600108 | LMGP03010246 |
| PS(19:0/22:0) | 863.70578 | 25.48655768 | LMGP03010475 |
| PS(22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 887.5043945 | 106.6639534 | LMGP01030018 |
Figure 4.

Venn diagram showing common and unique lipid species found in control areas and CDK affected areas, for CDK grade 1 (superior panel) and CDK grade 2 (inferior panel), for PC and PS. Diagram intersections’ show common lipids between control and affected areas.
Table 3.
Common phospholipid species identified in both, control and CDK affected areas.
| m/z* | Amount, pmol per Species/μg protein | LIPIDMAPS ID | |
|---|---|---|---|
| Phosphatydilcholines | |||
| Grade 1 | |||
| PC(2:0/0:0) | 294.646521 | 119.0274412 | LMGP01050043 |
| PC(0:0/3:1(2E)) | 312.3085632 | 0.955340492 | LMGP01050088 |
| PC(0:0/4:0) | 328.5174103 | 171.4947089 | LMGP01050089 |
| PC(2:0/2:0) | 345.2589264 | 25.29684283 | LMGP01010992 |
| PC(6:0/0:0) | 360.7000733 | 85.34025255 | LMGP01050062 |
| PC(3:0/3:0) | 373.3088633 | 158.4236004 | LMGP01011215 |
| PC(8:0/0:0) | 390.3349152 | 28.19330422 | LMGP01050066 |
| PC(O-10:1(9E)/0:0) | 399.1379204 | 50.14397867 | LMGP01060027 |
| PC(10:0/0:0) | 414.0388184 | 168.5467928 | LMGP01050005 |
| PC(5:0/5:0) | 430.6288147 | 301.5102334 | LMGP01011225 |
| PC(12:0/0:0) | 442.1364975 | 41.97399351 | LMGP01050009 |
| PC(O-11:1(10E)/2:0) | 458.1137187 | 142.0015605 | LMGP01020146 |
| PC(14:1(9Z)/0:0) | 468.9347534 | 134.0907124 | LMGP01050014 |
| PC(15:1(9Z)/0:0) | 482.7285462 | 316.4143978 | LMGP01050125 |
| PC(16:1(9Z)/0:0) | 498.2089463 | 308.5061021 | LMGP01050022 |
| PC(18:4(9E,11E,13E,15E)/0:0) | 520.5874023 | 1156.005517 | LMGP01050040 |
| PC(18:3(6Z,9Z,12Z)/0:0) | 525.5578613 | 188.3306353 | LMGP01050128 |
| PC(19:3(10Z,13Z,16Z)/0:0) | 537.7588501 | 1.693566016 | LMGP01050003 |
| PC(16:1(9Z)/2:0) | 542.2512207 | 69.99420119 | LMGP01010693 |
| PC(20:5(5Z,8Z,11Z,14Z,17Z)/0:0) | 549.6884155 | 496.3744142 | LMGP01050050 |
| PC(20:2(11Z,14Z)/0:0) | 555.9118652 | 328.6174258 | LMGP01050132 |
| PC(6:2(3E,5E)/14:2(11E,13E)) | 563.8403321 | 95.79849495 | LMGP01011236 |
| PC(18:1(9E)/2:0) | 569.2772339 | 861.9458746 | LMGP01010878 |
| PC(22:4(7Z,10Z,13Z,16Z)/0:0) | 579.3897247 | 264.4194871 | LMGP01050124 |
| PC(22:2(13Z,16Z)/0:0) | 582.6686401 | 34.07005381 | LMGP01050135 |
| PC(18:1(9Z)/4:0) | 598.3166504 | 305.8745425 | LMGP01010916 |
| PC(24:0/0:0) | 611.7825394 | 475.51746 | LMGP01050057 |
| PC(12:0/12:0) | 624.421875 | 311.3969386 | LMGP01010429 |
| PC(12:0/13:0) | 643.6590983 | 463.2832235 | LMGP01010001 |
| PC(12:0/15:1(9Z)) | 664.0793991 | 841.602332 | LMGP01011318 |
| PC(10:0/18:2(9Z,12Z)) | 677.8133087 | 689.7408956 | LMGP01010393 |
| PC(10:0/18:1(9Z)) | 684.8070069 | 220.5491298 | LMGP01010392 |
| PC(10:0/18:0) | 686.6455383 | 54.59223528 | LMGP01010390 |
| PC(12:0/18:1(9Z)) | 712.737854 | 17.62268556 | LMGP01010440 |
| PC(10:0/21:0) | 728.0479736 | 2.847456952 | LMGP01010396 |
| PC(12:0/20:5(5Z,8Z,11Z,14Z,17Z)) | 732.6423645 | 98.46496859 | LMGP01011333 |
| PC(13:0/20:5(5Z,8Z,11Z,14Z,17Z)) | 747.0627747 | 22.27042735 | LMGP01011357 |
| PC(13:0/20:4(5Z,8Z,11Z,14Z)) | 749.2914124 | 41.31325122 | LMGP01011356 |
| PC(15:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 799.3400269 | 16.9228596 | LMGP01011461 |
| PC(17:0/20:4(5Z,8Z,11Z,14Z)) | 804.3778992 | 54.65130021 | LMGP01010003 |
| PC(17:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 826.1033936 | 17.78568203 | LMGP01011550 |
| PC(16:0/23:5(8E,11E,14E,17E,20E)) | 830.2391357 | 8.993563427 | LMGP01010656 |
| PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 886.4762269 | 41.85462361 | LMGP01011119 |
| PC(23:1(9Z)/23:1(9Z)) | 927.0930237 | 134.2862697 | LMGP01011141 |
| PC(24:1(15Z)/24:1(15Z)) | 952.9333598 | 203.7302272 | LMGP01011163 |
| PC(22:0/26:0) | 965.081604 | 37.28316211 | LMGP01011107 |
| PC(34:0/16:0) | 984.7036705 | 51.08762534 | LMGP01011218 |
| Grade 2 | |||
| PC(2:0/0:0) | 300.7475204 | 3.981478114 | LMGP01050043 |
| PC(0:0/3:1(2E)) | 316.1439412 | 25.57478466 | LMGP01050088 |
| PC(0:0/4:0) | 330.2403361 | 2.286290765 | LMGP01050089 |
| PC(2:0/2:0) | 343.6709595 | 22.23310934 | LMGP01010992 |
| PC(6:0/0:0) | 358.9837341 | 95.66402265 | LMGP01050062 |
| PC(3:0/3:0) | 370.5003433 | 195.937209 | LMGP01011215 |
| PC(8:0/0:0) | 391.1658936 | 0.226786815 | LMGP01050066 |
| PC(O-10:1(9E)/0:0) | 397.5191345 | 3.512329217 | LMGP01060027 |
| PC(4:0/4:0) | 406.9981689 | 15.65223013 | LMGP01011222 |
| PC(10:0/0:0) | 416.5296326 | 196.4323143 | LMGP01050005 |
| PC(5:0/5:0) | 429.5228831 | 23.91039676 | LMGP01011225 |
| PC(12:0/0:0) | 440.451149 | 8.562903876 | LMGP01050009 |
| PC(6:2(2E,4E)/6:2(2E,4E)) | 451.0426025 | 1.262407207 | LMGP01011235 |
| PC(O-11:1(10E)/2:0) | 459.2329407 | 2.376642324 | LMGP01020146 |
| PC(14:1(9Z)/0:0) | 470.2901306 | 0.666841011 | LMGP01050014 |
| PC(15:1(9Z)/0:0) | 484.2517853 | 117.2943671 | LMGP01050125 |
| PC(16:1(9Z)/0:0) | 497.7138443 | 0.415454367 | LMGP01050022 |
| PC(O-14:0/2:0) | 504.4213715 | 0.191977505 | LMGP01020019 |
| PC(O-17:0/0:0) | 505.3683929 | 135.6667898 | LMGP01060013 |
| PC(8:2(2E,4E)/8:2(2E,4E)) | 509.2782364 | 9.147315957 | LMGP01011254 |
| PC(17:2(9Z,12Z)/0:0) | 514.7207642 | 145.624321 | LMGP01050127 |
| PC(17:1(9Z)/0:0) | 516.0500488 | 173.0182473 | LMGP01050126 |
| PC(18:3(6Z,9Z,12Z)/0:0) | 525.7462158 | 210.0639731 | LMGP01050128 |
| PC(0:0/18:1(9Z)) | 529.6395264 | 44.11870543 | LMGP01050082 |
| PC(O-16:0/2:0) | 531.8207397 | 0.202057957 | LMGP01020046 |
| PC(19:3(10Z,13Z,16Z)/0:0) | 538.7858124 | 1.225915616 | LMGP01050003 |
| PC(16:1(9Z)/2:0) | 542.2966309 | 2.055870035 | LMGP01010693 |
| PC(20:5(5Z,8Z,11Z,14Z,17Z)/0:0) | 549.8468933 | 1.663656827 | LMGP01050050 |
| PC(6:2(3E,5E)/14:2(11E,13E)) | 562.7392883 | 129.1237968 | LMGP01011236 |
| PC(18:1(9E)/2:0) | 570.3476563 | 3.703695673 | LMGP01010878 |
| PC(22:4(7Z,10Z,13Z,16Z)/0:0) | 580.1956787 | 21.28910443 | LMGP01050124 |
| PC(16:0/5:1(4E)) | 586.2541809 | 9.473000368 | LMGP01010673 |
| PC(18:1(9Z)/4:0) | 601.3341064 | 0.548999836 | LMGP01010916 |
| PC(24:0/0:0) | 610.3458252 | 48.39189195 | LMGP01050057 |
| PC(12:0/12:0) | 620.5292664 | 69.65722502 | LMGP01010429 |
| PC(12:0/13:0) | 638.8419088 | 83.83930245 | LMGP01010001 |
| PC(12:0/14:1(9Z)) | 645.7624207 | 0.657894935 | LMGP01011316 |
| PC(12:0/15:1(9Z)) | 664.4971771 | 3.292237794 | LMGP01011318 |
| PC(10:0/18:2(9Z,12Z)) | 677.1966705 | 128.2524298 | LMGP01010393 |
| PC(10:0/18:0) | 685.7401123 | 96.26273872 | LMGP01010390 |
| PC(12:0/17:2(9Z,12Z)) | 691.0081787 | 2.483937833 | LMGP01011322 |
| PC(18:0/11:1(10E)) | 699.3982849 | 1.484629256 | LMGP01010735 |
| PC(12:0/18:4(6Z,9Z,12Z,15Z)) | 701.6916199 | 0.222956068 | LMGP01011326 |
| PC(10:0/20:0) | 713.9262695 | 1.332221436 | LMGP01010395 |
| PC(13:0/18:4(6Z,9Z,12Z,15Z)) | 718.4020233 | 2.416812887 | LMGP01011351 |
| PC(14:0/18:4(6Z,9Z,12Z,15Z)) | 734.6452637 | 50.92343205 | LMGP01010499 |
| PC(14:0/18:3(9Z,12Z,15Z)) | 735.803833 | 57.74795118 | LMGP01010497 |
| PC(14:0/18:2(11Z,14Z)) | 738.2484741 | 1.165634299 | LMGP01010494 |
| PC(14:0/18:1(11Z)) | 741.1770325 | 0.763261748 | LMGP01010490 |
| PC(13:0/20:5(5Z,8Z,11Z,14Z,17Z)) | 744.3664246 | 1.517228029 | LMGP01011357 |
| PC(15:0/18:1(11Z)) | 754.477356 | 0.833595162 | LMGP01010541 |
| PC(12:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 757.8933716 | 0.830715782 | LMGP01010447 |
| PC(14:0/20:4(5Z,8Z,11Z,14Z)) | 762.9011078 | 31.29192158 | LMGP01010506 |
| PC(16:0/18:2(10E,12Z)) | 765.7141113 | 16.23479689 | LMGP01010585 |
| PC(10:0/24:0) | 770.1452637 | 2.13800887 | LMGP01010400 |
| PC(15:0/20:3(8Z,11Z,14Z)) | 778.9407043 | 1.169170041 | LMGP01011423 |
| PC(16:0/20:4(5Z,8Z,11Z,14Z)) | 789.7157288 | 37.82410851 | LMGP01010007 |
| PC(15:1(9Z)/22:4(7Z,10Z,13Z,16Z)) | 801.9890137 | 1.363450938 | LMGP01011460 |
| PC(17:0/20:4(5Z,8Z,11Z,14Z)) | 804.8378601 | 0.448589654 | LMGP01010003 |
| PC(16:0/22:6(4E,7E,10E,13E,16E,19E)) | 814.1509705 | 1.124265111 | LMGP01010650 |
| PC(16:0/22:4(7Z,10Z,13Z,16Z)) | 818.4989014 | 1.446115056 | LMGP01010642 |
| PC(18:0/20:3(5Z,11Z,14Z)) | 821.5475159 | 1.178012109 | LMGP01010795 |
| PC(17:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 826.6335449 | 43.84880809 | LMGP01011550 |
| PC(18:4(6Z,9Z,12Z,15Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 835.464447 | 1.54416391 | LMGP01011730 |
| PC(18:3(6Z,9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 836.2970886 | 1.422869593 | LMGP01011670 |
| PC(18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 838.7856903 | 2.5963024 | LMGP01010947 |
| PC(18:0/22:4(7Z,10Z,13Z,16Z)) | 847.0201721 | 42.56806052 | LMGP01010813 |
| PC(16:0/24:1(15Z)) | 852.4560547 | 0.756871684 | LMGP01010659 |
| PC(20:2(11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 867.4215088 | 1.056135248 | LMGP01011865 |
| PC(20:1(11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 868.4871216 | 1.518624943 | LMGP01011834 |
| PC(20:0/22:4(7Z,10Z,13Z,16Z)) | 873.7175903 | 1.454865821 | LMGP01011804 |
| PC(18:0/24:1(15Z)) | 880.6356201 | 1.500554735 | LMGP01010826 |
| PC(16:0/26:0) | 882.6246948 | 0.947456718 | LMGP01010663 |
| PC(21:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 884.5966187 | 0.994330628 | LMGP01010004 |
| PC(21:0/22:4(7Z,10Z,13Z,16Z)) | 889.1891479 | 0.273602214 | LMGP01011979 |
| PC(22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 894.450531 | 1.460927121 | LMGP01012065 |
| PC(22:1(11Z)/22:2(13Z,16Z)) | 905.4901733 | 1.428776634 | LMGP01012032 |
| PC(22:1(13E)/22:1(13E)) | 906.8718414 | 2.833697169 | LMGP01011108 |
| PC(18:0/26:0) | 910.887207 | 0.778367357 | LMGP01010828 |
| PC(23:1(9Z)/23:1(9Z)) | 927.9228668 | 2.87855425 | LMGP01011141 |
| PC(22:0/24:1(15Z)) | 936.1557312 | 0.531377092 | LMGP01011105 |
| PC(20:0/26:0) | 938.6951904 | 0.372342145 | LMGP01011034 |
| PC(24:1(15Z)/24:1(15Z)) | 950.0507507 | 121.4692795 | LMGP01011163 |
| PC(22:0/26:0) | 965.9285583 | 1.449679534 | LMGP01011107 |
| PC(34:0/16:0) | 984.3062998 | 7.685921442 | LMGP01011218 |
| Phosphatydilserines | |||
| Grade 1 | |||
| PS(12:0/0:0) | 440.4143036 | 2793.388271 | LMGP03050008 |
| PS(6:0/6:0) | 457.8782501 | 772.5812763 | LMGP03010020 |
| PS(14:0/0:0) | 470.6537933 | 2681.892134 | LMGP03050009 |
| PS(15:1(9Z)/0:0) | 480.2579575 | 2310.389423 | LMGP03050015 |
| PS(16:0/0:0) | 496.9708455 | 365.5803313 | LMGP03050002 |
| PS(18:1(9Z)/0:0) | 522.1900024 | 1940.676303 | LMGP03050001 |
| PS(19:1(9Z)/0:0) | 535.2797623 | 850.3865587 | LMGP03050019 |
| PS(20:4(5Z,8Z,11Z,14Z)/0:0) | 545.4216919 | 111.6436172 | LMGP03050007 |
| PS(10:0/10:0) | 565.9069214 | 1667.852742 | LMGP03010022 |
| PS(12:0/12:0) | 622.0140991 | 175.9625895 | LMGP03010027 |
| PS(12:0/13:0) | 638.8652649 | 268.9540205 | LMGP03010001 |
| PS(12:0/14:1(9Z)) | 653.2467041 | 153.7468114 | LMGP03010046 |
| PS(14:0/12:0) | 654.826416 | 285.2899071 | LMGP03010931 |
| PS(12:0/15:0) | 663.7553711 | 79.64711642 | LMGP03010047 |
| PS(14:0/14:0) | 675.4645996 | 45.88818134 | LMGP03010028 |
| PS(12:0/17:2(9Z,12Z)) | 686.1657104 | 131.8011401 | LMGP03010052 |
| PS(12:0/17:1(9Z)) | 686.7450867 | 376.4542771 | LMGP03010051 |
| PS(12:0/17:0) | 693.3683065 | 150.2897921 | LMGP03010050 |
| PS(12:0/18:2(9Z,12Z)) | 699.5421143 | 140.4609379 | LMGP03010053 |
| PS(13:0/18:2(9Z,12Z)) | 714.3778687 | 25.41099612 | LMGP03010078 |
| PS(17:0/14:1(9Z)) | 718.2476654 | 122.289291 | LMGP03010006 |
| PS(12:0/19:0) | 726.2710266 | 42.10891676 | LMGP03010057 |
| PS(16:0/16:0) | 735.1644775 | 569.4678808 | LMGP03010029 |
| PS(12:0/21:0) | 748.2671509 | 1740.017591 | LMGP03010064 |
| PS(16:0/18:1(11Z)) | 761.6001587 | 22.96151068 | LMGP03010007 |
| PS(13:0/22:1(11Z)) | 770.7945557 | 2.285220437 | LMGP03010089 |
| PS(13:0/22:0) | 775.6061401 | 94.64329165 | LMGP03010088 |
| PS(18:2(9Z,12Z)/18:2(9Z,12Z)) | 781.9361877 | 112.3843186 | LMGP03010023 |
| PS(17:0/20:4(5Z,8Z,11Z,14Z)) | 795.7001953 | 998.0748387 | LMGP03010003 |
| PS(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 804.4544678 | 88.11515529 | LMGP03010043 |
| PS(18:0/20:4(5Z,8Z,11Z,14Z)) | 806.6505737 | 97.02972519 | LMGP03010039 |
| PS(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 836.5066528 | 322.1845042 | LMGP03010040 |
| PS(18:0/22:1(11Z)) | 845.3986003 | 1022.9785 | LMGP03010320 |
| PS(19:0/22:0) | 865.8910522 | 257.3924868 | LMGP03010475 |
| PS(20:0/22:1(11Z)) | 870.6346842 | 168.337861 | LMGP03010525 |
| PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 883.2276306 | 84.36108425 | LMGP01030017 |
| PS(22:4(7Z,10Z,13Z,16Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 888.2210693 | 100.7549591 | LMGP01030018 |
| PS(22:0/22:1(11Z)) | 902.2740682 | 739.7834825 | LMGP03010722 |
| PS(22:0/22:0) | 908.0455933 | 99.37037004 | LMGP03010943 |
| PS(8:0/8:0) | 1535.316406 | 3393.87959 | LMGP03010021 |
| Grade 2 | |||
| PS(6:0/6:0) | 456.8153992 | 30698.24075 | LMGP03010020 |
| PS(14:0/0:0) | 465.2920074 | 203.8807057 | LMGP03050009 |
| PS(15:1(9Z)/0:0) | 484.0389252 | 1108.446661 | LMGP03050015 |
| PS(16:0/0:0) | 494.9042969 | 52469.15679 | LMGP03050002 |
| PS(17:2(9Z,12Z)/0:0) | 505.7750702 | 25458.10288 | LMGP03050016 |
| PS(18:1(9Z)/0:0) | 522.9552917 | 27456.93029 | LMGP03050001 |
| PS(20:4(5Z,8Z,11Z,14Z)/0:0) | 544.1977437 | 2318.998246 | LMGP03050007 |
| PS(20:0/0:0) | 553.0429688 | 526.7623955 | LMGP03050012 |
| PS(10:0/10:0) | 569.5486145 | 9698.171378 | LMGP03010022 |
| PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0) | 572.4798279 | 8951.025196 | LMGP03050013 |
| PS(22:1(11Z)/0:0) | 582.1560364 | 16767.76244 | LMGP03050023 |
| PS(12:0/12:0) | 624.1285095 | 4540.48997 | LMGP03010027 |
| PS(12:0/14:1(9Z)) | 650.6720479 | 19941.5584 | LMGP03010046 |
| PS(12:0/15:0) | 669.9039307 | 514.3605395 | LMGP03010047 |
| PS(12:0/17:0) | 697.3886719 | 5536.324964 | LMGP03010050 |
| PS(12:0/18:2(9Z,12Z)) | 700.0890503 | 472.5421882 | LMGP03010053 |
| PS(17:0/14:1(9Z)) | 721.6215363 | 26279.15042 | LMGP03010006 |
| PS(16:0/16:0) | 737.6786804 | 4369.155673 | LMGP03010029 |
| PS(13:0/20:2(11Z,14Z)) | 741.8208008 | 1566.624098 | LMGP03010084 |
| PS(13:0/20:1(11Z)) | 742.5445557 | 985.938965 | LMGP03010083 |
| PS(12:0/21:0) | 751.5957794 | 18965.41756 | LMGP03010064 |
| PS(16:0/18:1(11Z)) | 764.1244914 | 4240.293661 | LMGP03010007 |
| PS(13:0/22:0) | 775.519104 | 119.9065759 | LMGP03010088 |
| PS(18:2(9Z,12Z)/18:2(9Z,12Z)) | 787.125 | 665.3150824 | LMGP03010023 |
| PS(18:0/18:1(9Z)) | 791.3975525 | 12003.57914 | LMGP03010025 |
| PS(17:0/20:4(5Z,8Z,11Z,14Z)) | 797.8404948 | 3217.740952 | LMGP03010003 |
| PS(16:0/22:1(11Z)) | 820.0691732 | 3110.351725 | LMGP03010199 |
| PS(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | 839.9198608 | 1050.759611 | LMGP03010040 |
| PS(18:0/22:1(11Z)) | 845.3218384 | 2133.385921 | LMGP03010320 |
| PS(19:0/21:0) | 851.4665375 | 29861.94664 | LMGP03010474 |
| PS(19:0/22:1(11Z)) | 854.967041 | 1085.657158 | LMGP03010476 |
| PS(20:0/22:1(11Z)) | 870.8126221 | 3280.083414 | LMGP03010525 |
| PS(21:0/22:0) | 889.1227112 | 1632.461271 | LMGP03010698 |
| PS(22:0/22:2(13Z,16Z)) | 896.3721924 | 1235.249654 | LMGP03010723 |
| PS(22:0/22:1(11Z)) | 901.10554 | 2192.570608 | LMGP03010722 |
| PS(8:0/8:0) | 1023.023682 | 19258.31146 | LMGP03010021 |
In case of PS, 13 unique species were found in control areas and 8 in CDK affected areas from grade 1. For grade 2, 19 PS and 9 PS species were found in control and CDK areas, respectively (table 2, figure 4). Forty PS and 36 species were common between control and affected areas from grade 1 and grade 2, respectively (table 3, figure 4).
DISCUSION
CDK is a rare corneal degenerative disease characterized by progressive opacity because of accumulation of translucent material in the Bowman layer of the cornea within the interpalpebral fringe (Gray et al., 1992; Urrets-Zavalía et al., 2006, 2007). We have previously shown that CDK occurred in individuals who have lived their entire life under certain unfavorable environmental conditions such as high exposure to UVR, chronic micro erosions of the cornea, low levels of ascorbic acid (AA) in their diets and serum, and lack of protection with sunglasses or hats (Suarez et al., 2015). For those reasons we have previously proposed that this corneal disease should be call environmental proteinaceous corneal degenerative disease instead of climatic droplet keratopathy (Suarez et al, 2015).
The precise chemical nature of globules accumulated under the corneal epithelium remains uncertain despite many efforts have been made to unravel its composition (Tabbara, 1986; Kaji et al., 2007; Menegay et al., 2008; Kaji et al., 2010). It has been suggested that corneal deposits are derived from plasma proteins that, after reaching an inflamed cornea from the limbal vessels, are degraded by excessive exposure to UVR (Gray et al., 1992). Although no mechanistic link between UVR exposure and CDK has been established, Holopainen et al. have addressed this issue analyzing tears and corneal specimens obtained from CDK affected eyes. They found that CDK samples have higher levels of MMP-2, MMP-9, and pro inflammatory cytokines than unaffected individuals (Holopainen et al., 2012). They hypothesized that these proteins are produced by the corneal epithelium, and showed that UVR-B is capable of inducing pro-inflammatory response in these cells with concomitant increase in MMP-2 and MMP-9 levels. This is then likely to increase the apoptotic/ necrotic response of the corneal epithelial cells, harm the integrity of the basement membrane, and, eventually, lead to visible changes in the corneal architecture.
Recently, we performed a study in which two groups of guinea pigs were exposed during 30 months to daily doses of UVR-B similar to the one received by CDK patients living in Patagonia Argentina, fed with AA sufficient or AA partially deficient diets, respectively. Superficial corneal debridement wounds were made in one eye using a rotating burr (Algerbrush II, Ambler Surgical, Exton, PA, USA) at the nasal or temporal corneal limbus (once a week, alternating each region) previous topical anesthetic applied on the ocular surface (proparacaine ophthalmic solution, Alcon laboratories Argentina, Buenos Aires, Argentina). We found that guinea pig corneal epithelial cell levels of MMP-9 were increased, and that ALDH3A1 activity (most abundant soluble protein in the cornea, Estey et al., 2007) was increased during the first 18 months and then it decayed. The lipid peroxidation marker malondialdehyde (MDA) (Grotto, 2009) concentration followed the same pattern than ALDH3A1 activity. Moreover, we found that animals fed with deficient AA diet showed more pronounced abnormalities in the cornea and in the crystalline lens (unpublished data). All these findings are compatible with a state of chronic oxidative stress.
It is well known that combination of near continual exposure of the cornea and ocular surface to UVR and molecular oxygen can provoke oxidative stress and tissue damage. Oxidative stress can be defined as an imbalance between reactive oxygen species (ROS) and antioxidants (Cejka and Cejkova, 2015). Among the antioxidants we can mention enzymatic and non-enzymatic molecules. Some of the enzymatic antioxidants are constituted by aldehyde dehydrogenases (ALDHs), catalase, and superoxide dismutase (Chance et al., 1979; Fridovich, 1995; Harrison and Arosio, 1996; Chen et al., 2013), whereas AA, reduced glutathione (GSH), α-tocopherol and NAD(P)H are among the non-enzymatic antioxidants (Dickinson and Forman, 2002; Machlin and Bendich, 1987).
Oxidative stress can cause peroxidation and further damage of lipids, nucleic acids, bases, and proteins. The eye is one of the major targets of the ROS and reactive nitrogen species (RNS) attack due to exposition to several environmental factors like high pressure of oxygen, light, UVR, ionizing radiation, chemical pollutants and pathogenic microbes, which are able to shift the redox status of a cell towards oxidizing conditions. There is increasing evidence indicating that persistent oxidative stress contributes to the development of many ocular diseases such as certain types of keratitis, pterygium, and pinguecula, among others (Kruk et al., 2015).
Our hypothesis for CDK genesis is that individuals with prolonged corneal exposure to multiple unfavorable environmental conditions (e.g., excessive UVR-B exposure, lack of vegetation/shade, dry/windy climate, particle bombardment, AA partial nutritional deficiency, lack of eye protection, genetic factors, etc.) would develop inflammatory processes and oxidative stress leading to progressive degradation and accumulation of proteinaceous material in Bowman’s layer and, in advances cases of the disease, in the superficial stroma and deep epithelium (Urrets-Zavalia et al., 2012; Holopainen et al., 2012; Serra et al., 2015).
In the present study, we have determined phospholipids (PC and PS) present in control and CDK affected areas from patients’ corneas using triple quadrupole mass spectrometry, in parent-ion and neutral loss scan modes with parameters previously established in the lipid field and widely used for ocular tissue in the study of some ophthalmological diseases (Han et al., 2012; Bhattacharya, 2013; Wang et al., 2016). Phospholipids are the basic building blocks of cell membranes, arranged as bilayer membranes. Membrane phospholipids create a hydrophobic environment for transmembrane protein function and communication. Some membrane lipids are substrates for production of lipid second messengers, which are metabolized by enzymatic activity from phospholipid precursors (Fahy et al., 2011; Aribindi et al., 2013b; Edwards et al., 2014; Li et al., 2015).
Corneal lipid content was studied in humans and animals many years ago (Feldman, 1967; Broekhuyse, 1968; Bazan and Bazan, 1984). Bazan et al. (1984) established that corneal rabbit epithelium has larger phospholipid content and more saturated than in the rest of the cornea. Conversely, corneal endothelium has a higher unsaturation level, according with water permeability of this layer (three times higher than in epithelium). Herein, we report data that clearly shows decreased levels of total phospholipids, PC and PS in the affected CDK epithelium area (in grade 1 as well as grade 2) compared to the non-affected areas. We also describe phospholipids uniquely enriched in control areas, and others only present in CDK affected areas (table 2). At the same time, corneal epithelial cells from CDK grade 1 and grade 2 patients’ eyes present a common PC and PS composition (table 3).
It is known that UVR can induce lipid peroxidation in many cell types including human corneal epithelial cells. UVR leads to the production of ROS that initiate lipid peroxidation by attacking the polyunsaturated fatty acids chains in cell membrane phospholipids, and may cause the accumulation of reactive aldehydes. Unlike ROS, aldehydes are generally long-lived compounds that can diffuse through the cell and react with biological targets distant from the site of origin (Estey et al., 2007). Lipid peroxidation has been involved in several disorders such as atherogenesis, neurodegenerative diseases, cataractogenesis, and retinopathy (Awasthi et al., 1996; Witting et al., 1999; Butterfield et al., 2001; Kumar et al., 2001; Totan et al., 2001). Lipid peroxidation as a consequence of oxidative stress may have been taking place in corneas from CDK patients. This could account for the reduction in phospholipid concentrations that was observed.
In summary, we have studied for the first time phospholipid composition in corneal epithelial cells from CDK patients using shotgun lipidomics (direct infusion in triple quadrupole mass spectrometry), and we have found new evidences in favor of our hypothesis about the etiopathogenesis of CDK. The lower total amount of phospholipids observed in affected areas compared to control areas, and a differential composition between healthy corneal epithelial areas and CDK affected areas, could be signs of an active oxidative stress process occurring in CDK corneas.
Acknowledgments
We thank Yennifer Guerra for assistance with bioinformatic analyses.
This work was partly supported by a grant FONCYT from Argentina, and an unrestricted grant to University of Miami from Research to Prevent Blindness (RPB), NIH grants EY016112 and EY14801, Department of Defense grant W81XWH-15-1-0079.
Footnotes
CONFLICT OF INTERESTS
The authors declare that there is no conflict of interests regarding the publication of this paper.
References
- Aribindi K, Guerra Y, Lee RK, Bhattacharya SK. Comparative phospholipid profiles of control and glaucomatous human trabecular meshwork. Invest Ophthalmol Vis Sci. 2013a;54:3037–3044. doi: 10.1167/iovs.12-10517. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Aribindi K, Guerra Y, Piqueras MC, Banta JT, Lee RK, Bhattacharya SK. Cholesterol and glycosphingolipids of human trabecular meshwork and aqueous humor: comparative profiles from control and glaucomatous donors. Curr Eye Res. 2013b;38:1017–1026. doi: 10.3109/02713683.2013.803123. [DOI] [PubMed] [Google Scholar]
- Awasthi S, Srivatava SK, Piper JT, Singhal SS, Chaubey M, Awasthi YC. Curcumin protects against 4-hydroxy-2-transnonenal-induced cataract formation in rat lenses. Am J Clin Nutr. 1996;64:761–766. doi: 10.1093/ajcn/64.5.761. [DOI] [PubMed] [Google Scholar]
- Baquis E. Die colloïde Degeneration der Cornea. Ein Beitragzur Kenntniss der Entstehung des Colloïdsausepithelialen Elementen. Albrecht von Graefes Archivfür Ophthalmologie. 1898;46:553–620. [Google Scholar]
- Bazan HE, Bazan NG. Composition of phospholipids and free fatty acids and incorporation of labeled arachidonic acid in rabbit cornea. Comparison of epithelium, stroma and endothelium. Curr Eye Res. 1984;3:1313–1319. doi: 10.3109/02713688409007418. [DOI] [PubMed] [Google Scholar]
- Bhattacharya SK. Recent advances in shotgun lipidomics and their implication for vision research and ophthalmology. Curr Eye Res. 2013;38:417–427. doi: 10.3109/02713683.2012.760742. [DOI] [PubMed] [Google Scholar]
- Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
- Broekhuyse RM. Phospholipids in tissues of the eye. Isolation, characterization and quantitative analysis by two dimensional thin-layer chromatography of diacyl and vinyl-ether phospholipids. Biochim Biophys Acta. 1968;152:307–315. doi: 10.1016/0005-2760(68)90038-6. [DOI] [PubMed] [Google Scholar]
- Butterfield DA, Drake J, Pocernich C, Castegna A. Evidence ofoxidative damage in Alzheimer’s disease brain: central role for amyloidbeta-peptide. Trends Mol Med. 2001;7:548–554. doi: 10.1016/s1471-4914(01)02173-6. [DOI] [PubMed] [Google Scholar]
- Cejka C, Cejkova J. Oxidative stress to the cornea, changes in corneal optical properties, and advances in treatment of corneal oxidative injuries. Oxid Med Cell Longev. 2015;591530 doi: 10.1155/2015/591530. 2015. Review. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev. 1979;59:527–605. doi: 10.1152/physrev.1979.59.3.527. [DOI] [PubMed] [Google Scholar]
- Checa A, Bedia C, Jaumot J. Lipidomic data analysis: tutorial, practical guidelines and applications. Anal Chim Acta. 2015;885:1–16. doi: 10.1016/j.aca.2015.02.068. [DOI] [PubMed] [Google Scholar]
- Chen Y, Thompson DC, Koppaka V, Jester JV, Vasiliou V. Ocular aldehyde dehydrogenases: protection against ultraviolet damage and maintenance oftransparency for vision. Prog Retin Eye Res. 2013;33:28–39. doi: 10.1016/j.preteyeres.2012.10.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dickinson DA, Forman HJ. Glutathione in defense and signaling: lessons from a small thiol. Ann NY Acad Sci. 2002;973:488–504. doi: 10.1111/j.1749-6632.2002.tb04690.x. [DOI] [PubMed] [Google Scholar]
- Edwards G, Aribindi K, Guerra Y, Bhattacharya SK. Sphingolipids and ceramides of mouse aqueous humor: Comparative profiles from normotensive and hypertensive DBA/2J mice. Biochimie. 2014;105:99–109. doi: 10.1016/j.biochi.2014.06.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Edwards G, Aribindi K, Guerra Y, Lee RK, Bhattacharya SK. Phospholipid profiles of control and glaucomatous human aqueous humor. Biochimie. 2014;101:232–247. doi: 10.1016/j.biochi.2014.01.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Enriquez-Algeciras M, Bhattacharya SK. Lipidomic mass spectrometry and its application in neuroscience. World J Biol Chem. 2013;4:102–110. doi: 10.4331/wjbc.v4.i4.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Estey T, Piatigorsky J, Lassen N, Vasiliou V. ALDH3A1: a corneal crystalline with diverse functions. Exp Eye Res. 2007;84:3–12. doi: 10.1016/j.exer.2006.04.010. [DOI] [PubMed] [Google Scholar]
- Fahy E, Subramaniam S, Murphy RC, et al. Update of the LIPID MAPS comprehensive classification system for lipids. J Lipid Res. 2009;50:S9–S14. doi: 10.1194/jlr.R800095-JLR200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fahy E, Cotter D, Sud M, Subramaniam S. Lipid classification, structures and tools. Biochim Biophys Acta. 2011;1811:637–647. doi: 10.1016/j.bbalip.2011.06.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Feldman GL. Human ocular lipids: Their analysis and distribution. Surv Ophthalmol E. 1967:207–243. [PubMed] [Google Scholar]
- Freedman A. Labrador keratopathy. Arch Ophthalmol. 1965;74:198–202. doi: 10.1001/archopht.1965.00970040200013. [DOI] [PubMed] [Google Scholar]
- Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem. 1995;64:97–112. doi: 10.1146/annurev.bi.64.070195.000525. [DOI] [PubMed] [Google Scholar]
- Fujishima H, Fukagawa K, Okada N, et al. Chemotactic responses of peripheral blood eosinophils to prostaglandin D2 in atopic keratoconjunctivitis. Ann Allergy Asthma Immunol. 2013;111:126–131. doi: 10.1016/j.anai.2013.05.027. [DOI] [PubMed] [Google Scholar]
- Gray RH, Johnson GJ, Freedman A. Climatic droplet keratopathy. Surv Ophthalmol. 1992;36:241–253. doi: 10.1016/0039-6257(92)90093-9. Review. [DOI] [PubMed] [Google Scholar]
- Grotto D. Importance of the lipid peroxidation biomarkers and methodological aspects for malondialdehyde quantification. Quím Nova. 2009;32:169–174. online. [Google Scholar]
- Ham BM, Jacob JT, Keese MM, Cole RB. Identification, quantification and comparison of major non-polar lipids in normal and dry eye tear lipidomes by electrospray tandem mass spectrometry. J Mass Spectrom. 2004;39:1321–1336. doi: 10.1002/jms.725. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Han X, Yang K, Gross RW. Multi-dimensional mass spectrometry-based shotgunlipidomics and novel strategies for lipidomic analyses. Mass Spectrom Rev. 2012;31:134–178. doi: 10.1002/mas.20342. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta. 1275:1996. 161–203. doi: 10.1016/0005-2728(96)00022-9. [DOI] [PubMed] [Google Scholar]
- Holopainen JM, Robciuc A, Cafaro TA, et al. Pro inflammatory cytokines and gelatinasesin climatic droplet keratopathy. Invest Ophthalmol Vis Sci. 2012;53:3527–3535. doi: 10.1167/iovs.12-9441. [DOI] [PubMed] [Google Scholar]
- Holopainen JM, Serra HM, Sánchez MC, et al. Altered expression of matrix metalloproteinases and their tissue inhibitors as possible contributors to corneal droplet formation in climatic droplet keratopathy. Acta Ophthalmol. 2011;89:569–574. doi: 10.1111/j.1755-3768.2009.01764.x. [DOI] [PubMed] [Google Scholar]
- Iverson SJ, Lang SL, Cooper MH. Comparison of the Bligh and Dyer and Folch methods for total lipid determination in a broad range of marine tissue. Lipids. 2001;36:1283–1287. doi: 10.1007/s11745-001-0843-0. [DOI] [PubMed] [Google Scholar]
- Kaji Y, Nagai R, Amano S, et al. Advanced glycation end product deposits in climatic droplet keratopathy. Br J Ophthalmol. 2007;91:85–88. doi: 10.1136/bjo.2006.099812. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kaji Y, Oshika T, Takazawa Y, et al. Accumulation of D-beta-aspartic acid-containing proteins in age-related ocular diseases. Chem Biodivers. 2010;7:1364–1370. doi: 10.1002/cbdv.200900329. [DOI] [PubMed] [Google Scholar]
- Kruk J, Kubasik-Kladna K, Aboul-Enein HY. The role of oxidative stress in the pathogenesis of eye diseases: current status and a dual role of physicalactivity. Mini Rev Med Chem. 2015;16:241–257. doi: 10.2174/1389557516666151120114605. [DOI] [PubMed] [Google Scholar]
- Kumar RS, Anthrayose CV, Iyer KV, Vimala B, Shashidhar S. Lipid peroxidation and diabetic retinopathy. Indian J Med Sci. 2001;55:133–138. [PubMed] [Google Scholar]
- Li J, Wang X, Zhang T, et al. A review on phospholipids and their main applications in drug delivery systems. Asian J of Pharmaceutical Sci. 2015;10:81–98. [Google Scholar]
- Liliom K, Guan Z, Tseng JL, Desiderio DM, Tigyi G, Watsky MA. Growthfactor-like phospholipids generated after corneal injury. Am J Physiol. 1998;274:1065–1074. doi: 10.1152/ajpcell.1998.274.4.C1065. [DOI] [PubMed] [Google Scholar]
- Machlin LJ, Bendich A. Free radical tissue damage: protective role ofantioxidant nutrients. FASEB J. 1987;1:441–445. [PubMed] [Google Scholar]
- Menegay M, Lee D, Tabbara KF, et al. Proteomic analysis of climatic keratopathy droplets. Invest Ophthalmol Vis Sci. 2008;49:2829–2837. doi: 10.1167/iovs.07-1438. [DOI] [PubMed] [Google Scholar]
- Rantamäki AH, Seppänen-Laakso T, Oresic M, Jauhiainen M, Holopainen JM. Human tear fluid lipidome: from composition to function. PLoS One. 2011;6:e19553. doi: 10.1371/journal.pone.0019553. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Robciuc A, Rantamäki AH, Jauhiainen M, Holopainen JM. Lipid-modifying enzymes in human tear fluid and corneal epithelial stress response. Invest Ophthalmol Vis Sci. 2014;55:16–24. doi: 10.1167/iovs.13-12577. [DOI] [PubMed] [Google Scholar]
- Serra HM, Holopainen JM, Beuerman R, Kaarniranta K, Suarez MF, Urrets-Zavalia JA. Climatic droplet keratopathy: an old disease in new clothes. Acta Ophthalmol. 2015;93:496–504. doi: 10.1111/aos.12628. [DOI] [PubMed] [Google Scholar]
- Suarez MF, Correa L, Crim N, et al. Climatic droplet keratopathyin Argentina: involvement of environmental agents in its genesis which would open the prospect for new therapeutic interventions. Biomed Res Int. 2015;527835 doi: 10.1155/2015/527835. 2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tabbara KF. Climatic droplet keratopathy. Int Ophthalmol Clin. 1986;26:63–68. doi: 10.1097/00004397-198602640-00006. [DOI] [PubMed] [Google Scholar]
- Totan Y, Cekic O, Borazan M, Uz E, Sogut S, Akyol O. Plasmamalondialdehyde and nitric oxide levels in age related macular degeneration. Br J Ophthalmol. 2001;85:1426–1428. doi: 10.1136/bjo.85.12.1426. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Urrets-Zavalia JA, Croxatto JO, Holopainen JM, et al. In vivo confocal microscopy study of climatic droplet keratopathy. Eye (Lond) 2012;26:1021–1023. doi: 10.1038/eye.2012.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Urrets-Zavalía JA, Maccio JP, Knoll EG, Cafaro TA, Urrets-Zavalía EA, Serra HM. Surface alterations, corneal hypoesthesia and iris atrophy in patients with climatic droplet keratopathy. Cornea. 2007;26:800–804. doi: 10.1097/ICO.0b013e31806bef31. [DOI] [PubMed] [Google Scholar]
- Wang M, Wang C, Han RH, Han X. Novel advances in shotgun lipidomicsforbiology and medicine. Prog Lipid Res. 2016;61:83–108. doi: 10.1016/j.plipres.2015.12.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Witting PK, Pettersson K, Ostlund-Lindqvist AM, Westerlund C, Eriksson AW, Stocker R. Inhibition by a coantioxidant of aortic lipoprotein lipid peroxidation and atherosclerosis in apolipoprotein E and low density lipoprotein receptor gene double knockout mice. FASEB J. 1999;13:667–675. doi: 10.1096/fasebj.13.6.667. [DOI] [PubMed] [Google Scholar]
- Yang K, Han X. Lipidomics: Techniques, Applications, and Outcomes Related to Biomedical Sciences. Trends Biochem Sci. 2016;41:954–969. doi: 10.1016/j.tibs.2016.08.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
